Turbo cancers are a rapidly escalating threat in the wake of the COVID pandemic, forcing doctors to push the boundaries of traditional oncology treatment. This presentation, ‘Emergence and Treatment of Turbo Cancers’, from February’s 2024 FLCCC Educational Conference in Phoenix, Arizona, featured Dr. Kathleen Ruddy, Dr. Paul Marik, and Dr. Nathan Goodyear, and introduced groundbreaking adjunctive treatment strategies that are reshaping cancer care.
Highlighting the role of repurposed drugs like ivermectin, alongside metabolic therapy and lifestyle modifications, the speakers presented a more personalized and less invasive approach to cancer treatment.
Here, Dr. Ruddy shares the progress she witnessed in three cancer patients being treated with ivermectin, the need for more research on the use of repurposed drugs in the treatment of cancer, and new observational study designed to do just this.
Watch:
Watch:
Learn:
